期刊文献+

人膀胱癌组织中细胞外基质金属蛋白酶诱导因子的表达 被引量:11

Expression of Extracellular Matrix Metalloproteinase Inducer in Human Bladder Transitional Cell Carcinoma
下载PDF
导出
摘要 背景与目的:基质金属蛋白酶(matrix metalloproteinases,MMPs)在恶性肿瘤的发生、浸润和转移中发挥关键作用,肿瘤细胞表达的细胞外基质金属蛋白酶诱导因子(extracellular matrix metalloproteinase inducer,EMMPRIN)司以诱导间质成纤维细胞合成MMPs,从而促进肿瘤的浸润和转移。本研究拟通过检测EMMPRIN在人膀胱癌组织和正常膀胱粘膜中的表达,探讨EMMPRIN在膀胱癌发生、浸润和转移中的作用。方法:应用免疫组化SP方法检测EMMPRIN在45例膀胱癌组织和9例正常膀胱粘膜中的表达,并与临床病理指标结合起来分析。结果;EMMPRIN蛋白定位于癌细胞的胞膜和胞浆,阳性率为73.3%,正常膀胱粘膜和肿瘤间质均为阴性表达。EMMPRIN在Ⅱ、Ⅲ级和术后复发组的阳性表达率分别为84.0%、84.6%和100%,高于Ⅰ级和无复发组(分别为14.3%和55.6%)(P<0.05);在淋巴结转移组的强阳性表达率(85.7%)高于无淋巴结转移组(23.7%)(P<0.05)。结论:EMMPRIN在人膀胱癌组织中过度表达,与膀胱癌的恶性程度有关,可作为判断膀胱 癌是否具备高侵袭转移潜能的指标。 BACKGROUND & OBJECTIVE: Matrix metalloproteinases(MMPs) play critical roles in the process of tumorigenesis, tumor invasion and metastasis. Extracellular matrix metalloproteinase inducer (EMMPRIN) derived from cancer cell can induce stromal fibroblasts to synthesize MMPs, which advances the invasion and metastasis of cancer. This study was designed to investigate the roles of EMMPRIN in the tumorigenesis, invasion and metastasis of bladder carcinoma by detecting the expression of EMMPRIN in human normal and carcinomatous bladder tissues. METHODS: The expression of EMMPRIN was examined in 45 bladder carcinoma tissues from 45 patients and normal bladder mucosa from 9 persons by immunohistochemistry SP method. The relationship between EMMPRIN expression and clinicopathologic parameters was analyzed. RESULTS: EMMPRIN protein was localized at membrane and cytoplasm of carcinomatous epithelial cell, but was not expressed in normal bladder epithelial or tumor stromal cell. The overall positive rate of EMMPRIN in 45 cases of bladder carcinoma was 73%. The positive rates of EMMPRIN in grade II, grade III and recurrent carcinomas were 84% , 85% , and 100% , respectively, significantly higher than those in grade I and non-recurrent carcinomas (14% and 56% , respectively) ( P <0. 05). The intensive positive rate of EMMPRIN in lymph node metastasis group (86% ) was significantly higher than that in no lymph node metastasis group (24%) (P<0. 05). CONCLUSION: EMMPRIN was overexpressed in human bladder transitional cell carcinoma, and related to the malignant degree and recurrence. It could be a useful indicator for the assessment of potent invasion and metastasis of bladder carcinoma.
出处 《癌症》 SCIE CAS CSCD 北大核心 2003年第11期1158-1161,共4页 Chinese Journal of Cancer
关键词 人膀胱癌 细胞外基质金属蛋白酶 诱导因子 免疫组化 检测 Extracellular matrix metalloproteinase inducer (EMMPRIN) Bladder carcinoma Immunohistochemistry
  • 相关文献

参考文献12

  • 1李莉,张声,林华,林建银.基质金属蛋白酶和组织金属蛋白酶抑制剂表达失衡与胃癌浸润转移的关系[J].癌症,2002,21(3):305-310. 被引量:57
  • 2沃尔什.坎贝尔泌尿外科学:第 7版[M].北京:科学出版社,2001.2361- 2370.
  • 3蔡威,宋今丹.基质金属蛋白酶及其组织抑制物在卵巢肿瘤中的表达[J].癌症,2002,21(1):91-94. 被引量:29
  • 4孙颖浩,杨庆.浅表性膀胱癌术后复发的预防[J].当代医学,2001,7(10):49-53. 被引量:4
  • 5Chambers AF, Marisian LM. Changing views of the role of matrix metalloproteinases in metastasis[J]. J Nat Cancer lnst, 1997,89:1260 - 1270.
  • 6Guo H, Li R, Zucker S, etal. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface[J]. Cancer Res, 2000, 60:888 - 891.
  • 7Dalberg K, Eriksson E, Enberg U, et al. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer[J]. World J Surg, 2000.24:334 - 340.
  • 8Ozdemir E, Kakehi Y, Okuno H, et al. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas[J]. J Urol, 1999, 161:1359 -1363.
  • 9Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis[J]. Eur J Cancer, 2000, 36: 1621- 1630.
  • 10Brown PD, Bloxidge RE, Anderson E, et al. Expression of activated gelatinase in human invasive breast carcinoma[J]. Clin Exp Metastasis, 1993, 11(2): 183-189.

二级参考文献22

  • 1Kachra Z,Beaulieu E,Delbecchi L,et al.Expression of matrix metalloproteinaes and their inhibitors in human brain tumors [J].Clin Exp metastasis,1999,17: 555-566.
  • 2Liotta LA,Stetler-Stevenson WG.Tumor invasion and metastasis: an imbalance of positive and negative regulation [J].Cancer Res (suppl),1991,51: 5054s-5059s.
  • 3Campo E,Merino MJ,Tavassoli FA,et al.Evaluation of basement membrane components and the 72 000 kDa type Ⅵ collagenase in serous tumors of the ovary [J].Am J Surg Pathol,1992,16: 500-507.
  • 4Autio-Harmainen H,Karttunen T,Hurskainen T,et al.Expression of 72 kilodalton type collagenase (Gelatinase A) in benign and malignant ovarian tumors [J].Lab Invest,1993,69: 312-321.
  • 5Furuya M,Ishikura H,Kawarada Y,et al.Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms [J].Gynecol Oncol,2000,78: 106-112.
  • 6Dolo V,D Ascenzo S,Violoni S,et al.Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer in vivo and in vitro [J].Clin Exp Metastasis,1999,17: 131-140.
  • 7ontgomery AMP,Mueller BM,Reisfeld RA,et al.Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line[J].Cancer Res,1994,54: 5467-5473.
  • 8Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metalloproteinase-2 inhibitors bFCF-induced human microvascular endothelial cell proliferation [J].J Cell Physiol,1993,157: 351-358.
  • 9Ylisirni S,H yhty M,Turpeenniemi-Hujanen T.Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer - TIMP-1 as a prognostic marker [J].Anticancer Res,2000,20: 1311-1316.
  • 10berg,H yhtya M,Tavelin B,et al.Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2,MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1,TIMP-2) in colorectal cancer [J].Anticancer Res,2000,20: 1085-1092.

共引文献87

同被引文献35

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部